Carlos Vrech
Overview
Explore the profile of Carlos Vrech including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Carnero Contentti E, Lopez P, Tkachuk V, Vrech C, Zarate M, Correale J, et al.
Mult Scler
. 2023 Jul;
29(10):1240-1249.
PMID: 37491849
Background: We aimed to assess the frequency of new asymptomatic lesions on brain and spinal imaging (magnetic resonance imaging (MRI)) and their association with subsequent relapses in a large cohort...
12.
Alonso R, Casas M, Lazaro L, Fernandez Liguori N, Pita C, Cohen L, et al.
Mult Scler J Exp Transl Clin
. 2023 Feb;
9(1):20552173231154712.
PMID: 36846108
Background: We aimed to determine the proportion of highly active multiple sclerosis patients under high-efficacy therapies (HETs) achieve no evidence of disease activity-3 (NEDA-3) at 1 and 2 years, and...
13.
Carra A, Vrech C, Valitutti G, Taiano C, Gonzalez Della Valle M, Bozzo R
Medicina (B Aires)
. 2023 Feb;
83(1):59-64.
PMID: 36774598
Introduction: There is limited local information on the risk of severe COVID-19 infection in patients with multiple sclerosis (MS) who are receiving disease-modifying treatments (DMT). The aim of the study...
14.
Rojas J, Pappolla A, Patrucco L, Cristiano E, Miguez J, Liwacki S, et al.
Neurol Sci
. 2022 Sep;
44(1):281-286.
PMID: 36166174
Methods: NMOSD patients diagnosed according to 2015 criteria and with MOGAD were identified. Patients with at least 3 years of follow-up and periodic clinical evaluations with EDSS outcomes were included....
15.
Rojas J, Luetic G, Vrech C, Pappolla A, Patrucco L, Cristiano E, et al.
Mult Scler Relat Disord
. 2022 Sep;
68:104104.
PMID: 36057175
Methods: cohort study conducted between May 2021 and December 2021. The primary outcome was the appearance of infection during the follow-up time (at least three months after complete vaccination (second...
16.
Luetic G, Menichini M, Vrech C, Pappolla A, Patrucco L, Cristiano E, et al.
Mult Scler Relat Disord
. 2022 Feb;
58:103401.
PMID: 35216784
Background: In multiple sclerosis demographics there is a well-known female prevalence and male patients have been less specifically evaluated in clinical studies, though some clinical differences have been reported between...
17.
Ciampi E, Guerra-Posada C, Trevino-Frenk I, Cortes-Enriquez F, Correa-Diaz E, Steinberg J, et al.
Mult Scler Relat Disord
. 2022 Feb;
59:103649.
PMID: 35124301
MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis have been recently published, and they have been fundamental for improving patient care. Implementation of these and...
18.
Alonso R, Garcea O, Rojas J, Alonso M, Lazaro L, Lopez P, et al.
Mult Scler Relat Disord
. 2022 Jan;
58:103483.
PMID: 35032883
Background PPMS (primary progressive multiple sclerosis) patients represent less than 10% of MS patients in Argentina, men and women were similarly affected and most of them had a severe functional...
19.
Carnero Contentti E, Lopez P, Pettinicchi J, Criniti J, Pappolla A, Miguez J, et al.
Mult Scler Relat Disord
. 2021 Dec;
58:103466.
PMID: 34929456
Background: Identification of triggers that potentially instigate attacks in neuromyelitis optica spectrum disorders (NMOSD) and multiple sclerosis (MS) has remained challenging. We aimed to analyze the seasonality of NMOSD and...
20.
Alonso R, Quarracino C, Eizaguirre B, Cohen L, Silva B, Pita C, et al.
Neurol Sci
. 2021 Sep;
42(12):5441.
PMID: 34557969
No abstract available.